Conversely, decreasing the level of miR-6741-3p by a synthetic miR-6741-3p inhibitor and, in turn, increasing the level of SRSF3 in OSCC cells might promote tumor formation in vivo. This evidence concerns the gene SRSF3 and neoplasm.